Author

R. Altares

Observed names: Raquel Altares, Raquel M. Altares

Institution: PharmaMar (Spain)

Observed institutions: The Netherlands Cancer Institute, PharmaMar (Spain)

ORCID: 0000-0003-3277-4492

Observed ORCID: 0000-0003-3277-4492

OpenAlex ID: A5017636088

Metabolic Disposition of Lurbinectedin, a Potent Selective Inhibitor of Active Transcription of Protein-Coding Genes, in Nonclinical Species and Patients

2022 · P. Aviles, R. Altares, et al. · Drug Metabolism and Disposition · 8

Quantitative determination of lurbinectedin, its unbound fraction and its metabolites in human plasma utilizing ultra-performance LC–MS/MS

2023 · Nicholas King, Soledad Garcia-Martinez, et al. · PLoS ONE · 5

Abstract 2972: Trabectedin exerts its potent and selective antitumor effects by irreversibly covalently bonding to duplex stem loops in G-quadruplexes

2025 · Alena Safarova, Marta Martínez Diez, et al. · Cancer Research · 2

Development of a new method for the quantitation of metabolites in the absence of chemically synthetized authentic standards

2019 · R. Altares, F.M. Márquez del Pino, et al. · Journal of Pharmaceutical and Biomedical Analysis · 2

Investigating the role of G-quadruplex-associated duplex stem loops in Trabectedin’s mechanism of action

2026 · Alena Safarova, Raquel Altares, et al. · Scientific Reports · 1

Works count: 5

Citation count: 18

H-index: 2

I10-index: